Plain-English translation of NCT06887907 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand how megakaryocytes—cells that make platelets—behave differently in people with sickle cell disease. By studying blood samples from patients during healthy periods and during sickle cell crises, they hope to learn whether these cells play a role in complications like acute chest syndrome and pain crises.
Sickle cell disease causes chronic inflammation and blood clotting problems that lead to serious complications. While doctors know that platelets become overactive in this disease, very little is known about the cells that produce them. Understanding these cells could reveal new ways to prevent or treat life-threatening complications like acute chest syndrome, which is the leading cause of death in sickle cell patients.
You likely qualify if…
You likely don't qualify if…
You will have a single blood sample drawn, similar to a routine blood test. Depending on your health status, you may be enrolled as someone in a stable period or during an active crisis. The study compares blood samples from 40 participants total across different health states to identify patterns in how these cells behave.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France
Enrollment target
~40 participants
Started
March 2025
Primary completion
April 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Pierre COUGOUL, MD
University Hospital, Toulouse
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.